Natera Inc.

Natera, Inc. leads global molecular diagnostics with a portfolio spanning non‑invasive prenatal, carrier and cancer surveillance tests, and transplant rejection assays. Strong partnerships with BGI Genomics and Foundation Medicine support expansion in precision healthcare.

Headquarters: United States (USA)

Natera Inc. Logo
Company Profile
  • Employees: 4,424
  • HQ: Austin
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
NTRA Natera Inc.
Cap: 32.7B
EQUITY NMS USD US6323071042 Active
📈
Home Login